Literature DB >> 31644962

Ginsenoside Rg3 promotes Fc gamma receptor-mediated phagocytosis of bacteria by macrophages via an extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent mechanism.

Chun Xin1, Joungmin Kim2, Hui Quan2, Mei Yin2, Seongtae Jeong3, Jeong-Il Choi2, Eun-A Jang3, Chang-Hun Lee2, Dae-Hun Kim2, Hong-Beom Bae4.   

Abstract

Ginsenoside Rg3 is a steroidal saponin abundant in Korean red ginseng that has high anti-inflammatory activity. Rg3 exerts an immunomodulatory effect in acute inflammatory conditions such as bacterial infections. In this study, we determined the effect of Rg3 on bacterial uptake by macrophages and the related intracellular signaling pathways. Rg3 increased macrophage phagocytosis of IgG-opsonized Escherichia coli and IgG-opsonized beads (IgGbeads), but not of non-opsonized beads. Rg3 also enhanced the phosphorylation of extracellular signal-regulated kinase (ERK) 1/2 and p38 mitogen-activated protein kinase (p38 MAPK), but not that of Akt. The inclusion of IgGbeads in macrophage cultures also increased the phosphorylation of ERK1/2 and p38, but co-culture of macrophages with non-opsonized beads did not affect the phosphorylation of ERK1/2 and p38. The Rg3-induced promotion of phagocytosis was inhibited by PD98059, an ERK1/2 inhibitor, and SB203580, a p38 inhibitor. PD98059 inhibited Rg3-induced p38 MAPK phosphorylation, but SB203580 did not suppress ERK1/2 phosphorylation. Culture of macrophages with Rg3 increased actin polymerization, and this effect was inhibited by SB203580 and PD98059. The Rg3-induced increase in phagocytosis was also inhibited by NSC23766, a Rac1 inhibitor and CASIN, a Cdc42 inhibitor. Intraperitoneal injection of Rg3 increased the phosphorylation of ERK1/2 and p38 as well as the phagocytosis of bacteria by lung cells. These results demonstrate that ginsenoside Rg3 enhances macrophage phagocytosis of bacteria by activating the ERK1/2 and p38 MAPK pathways.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ginsenoside Rg3; Macrophage; Mitogen activated protein kinases; Phagocytosis

Mesh:

Substances:

Year:  2019        PMID: 31644962     DOI: 10.1016/j.intimp.2019.105945

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  5 in total

Review 1.  Insights into the antitumor mechanism of ginsenosides Rg3.

Authors:  Zongyu Liu; Tongjun Liu; Wei Li; Jiannan Li; Cuizhu Wang; Kai Zhang
Journal:  Mol Biol Rep       Date:  2021-03-04       Impact factor: 2.316

Review 2.  Ginsenoside from ginseng: a promising treatment for inflammatory bowel disease.

Authors:  Zengping Kang; Youbao Zhonga; Tiantian Wu; Jiaqi Huang; Haimei Zhao; Duanyong Liu
Journal:  Pharmacol Rep       Date:  2021-01-19       Impact factor: 3.024

3.  Taurine and Ginsenoside Rf Induce BDNF Expression in SH-SY5Y Cells: A Potential Role of BDNF in Corticosterone-Triggered Cellular Damage.

Authors:  Won Jin Lee; Gyeong Hee Lee; Jinwoo Hur; Hyuk Gyoon Lee; Eunsu Kim; Jun Pil Won; Youngjae Cho; Mi-Jung Choi; Han Geuk Seo
Journal:  Molecules       Date:  2020-06-18       Impact factor: 4.411

Review 4.  Progress on the Elucidation of the Antinociceptive Effect of Ginseng and Ginsenosides in Chronic Pain.

Authors:  Mei-Xian Li; Qian-Qi Wei; Huan-Jun Lu
Journal:  Front Pharmacol       Date:  2022-02-21       Impact factor: 5.810

5.  The Antimicrobial Peptide Mastoparan X Protects Against Enterohemorrhagic Escherichia coli O157:H7 Infection, Inhibits Inflammation, and Enhances the Intestinal Epithelial Barrier.

Authors:  Xueqin Zhao; Lei Wang; Chunling Zhu; Xiaojing Xia; Shouping Zhang; Yimin Wang; Huihui Zhang; Yanzhao Xu; Shijun Chen; Jinqing Jiang; Shanqin Liu; Yundi Wu; Xilong Wu; Gaiping Zhang; Yueyu Bai; Hanna Fotina; Jianhe Hu
Journal:  Front Microbiol       Date:  2021-06-10       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.